INTRODUCTION
Toxins such as okadaic acid (OA) can induce apoptosis in most, if not all, animal cells. The death can be caspase dependent or caspase independent, and although enhanced by p53 (Yan et al., 1997) , can occur in cells devoid of p53 (Boe et al., 1991; Gjertsen et al., 1994; Fladmark et al., 1999; Morimoto et al., 1999; Sandal et al., 2001) . The first step in OA action requires inhibition of both of the major serine/threonine protein phosphatases PP1 and PP2A (Fladmark et al., 1999) . An early consequence of PP inhibition is hyperphosphorylation of a number of substrates of the multifunctional calmodulin-dependent protein kinase II (CaMKII). Inhibitors of CaMKII can abrogate OA-induced apoptosis (Fladmark et al., 2002) .
To gain more insight into the apoptogenic action of PP inhibitors, a functional cDNA library-based screening was undertaken, by using a Jurkat T-cell cDNA fragment library, to identify cDNAs able to protect against OA-induced death. One resistant cell clone had a cDNA (termed Oar-2) corresponding to part of a human gene (GenBank accession no. AK002158) (Sandal et al., 2001) . This gene has sequence similarity to a protein family characterized by GTP-binding and predicted protein-protein interaction domains of type coiled-coil or leucine-rich repeats. The protein family has members in plants mediating the hypersensitivity response to invading pathogens (Staskawicz et al., 1995; Moffett et al., 2002) , and members expressed in the mammalian immune system (Ian proteins) with hitherto unknown function (Krucken et al., 1997; Poirier et al., 1999; Daheron et al., 2001; Cambot et al., 2002; Hornum et al., 2002; MacMurray et al., 2002) . Little is known about the role of the GTP-binding domain, but it seems to be required for the response to pathogen of a plant resistance protein (Moffett et al., 2002) . The high number of genes, 10 human and 11 murine (MacMurray et al., 2002) , coding for mammalian Ian proteins, suggests functional diversity. This may be reflected by distinct subcellular localization. The Imap38-1/mIan2 is nuclear (Krucken et al., 1999) , mIan4 is mitochondrial (Daheron et al., 2001) , and hImap1/hIan2 is associated with the endoplasmic reticulum (ER) (Stamm et al., 2002) . Recently, the rat ortholog of AK002158 was identified as a major genetic locus responsible for the lymphopenic autoimmune diabetes type I in the BB rat (Hornum et al., 2002; MacMurray et al., 2002) . In the present study, the full-length cDNA of AK002158, cloned from a human spleen cDNA library, was demonstrated to protect specifically against death induced by OA or ␥-radiation, and hence named inhibitor of radiation-and OA-induced death, Irod/Ian5, or Irod for short. Full-length Irod was distributed in the centrosome/Golgi/endoplasmic reticulum compartments, which is a novel finding for a member of this protein family. Truncated Irod devoid of its C-terminal putative membrane anchor had full antiapoptotic effect and was confined to the centrosomal area. The centrosome receives increasing attention as being a signaling center, and not merely responsible for microtubule organization (Bornens, 2002; Meraldi and Nigg, 2002) . It contains the key enzymes (PP2A, PP1, and CaMKII) involved in the early steps of OA-induced apoptosis (Pietromonaco et al., 1995; Takahashi et al., 1999; Matsumoto and Maller, 2002) .
To our knowledge, Irod/Ian5 is the first Ian protein with an experimentally established function, i.e., to inhibit a CaMKII-dependent apoptosis pathway induced in response to ionizing radiation, and mimicked by PP inhibitors such as okadaic acid. An intriguing observation was that the putative GTP-binding domain of Irod was dispensable for the antiapoptotic action. The widespread expression of Irod, and its ability to counteract apoptosis also in nonimmune cells, suggests that its function may not be restricted to the immune system.
MATERIALS AND METHODS

Materials
Okadaic acid (0-8010), biszbenzimide fluorochrome (Hoechst 33342), camptothecin (C-9911), staurosporin (S-4400), daunorubicin (D-8809), doxorubicin (D1515), cycloheximide (C-6255), tumor necrosis factor (TNF)-␣ (T-0157), and bleomycin were from Sigma-Aldrich (St. Louis, MO). The CaMKII inhibitor KN93 was from Seikagaku America (Ijamsville, MD), and the caspase inhibitor z-val-ala-DL-asp-fluormethylketone (zVADfmk) was from Bachem Feinchemikal A.G. (Bubendorf, Switzerland) . The transfection reagent DMRIE-C was from Invitrogen (Paisley, United Kingdom).
Irod Cloning and Modification
A human spleen cDNA library (597; http://www.rzpd.de) was screened at the Deutsche Krebsforschungs Zentrum Resource Centre (Heidelberg, Germany), by using as probe the Oar2 cDNA fragment of 419 base pairs, isolated from an OA-resistant cell clone (Sandal et al., 2001) . The clone DKFZp597C0168Q3 was sequenced and found to contain a cDNA (in pSPORT1) corresponding to the full-length of a human gene (AK002158) encoding a human protein with unknown function (Irod).
For cell transfections, the Irod cDNA was excised from pSPORT1 with EcoR1/BamH1 for sense ligation and with NotI/EcoR1 for antisense ligation into pcDNA3.1/Myc-His (Invitrogen, San Diego, CA).
To visualize the localization of Irod and enable control that the whole protein sequence was present at a particular locus in the cell, the hemagglutinin (HA) epitope (YPYDVP-DYA) of the influenza virus was added in-frame (5Јor 3Ј) with Irod. These constructs were cloned into the BamH1/ EcoR1 site in a modified 96J-G (pJim-GFP) retrovirus vector (Lorens et al., 2000) , in-frame with green fluorescent protein (GFP), resulting in HA-Irod-GFP and Irod-HA-GFP. Truncated versions of HA-Irod were constructed with deleted GTP/GDP-binding domain (⌬GTP/GDP; deletion of amino acid 1-143) and deleted trans-membrane domain (⌬TM; deletion of amino acid 282-307).
Cell Handling and Scoring of Apoptosis
Human embryonic kidney cells (293T) were cultured in DMEM. Jurkat E-6 T lymphoma cells (American Type Culture Collection, Rockville, MD) and human prostate carcinoma cells (LNCaP; American Type Culture Collection) were grown in RPMI 1640 medium. LnCap cells stably expressing Bcl-2 (Beham et al., 1997) was a kind gift from T.J. McDonnell (The MD Anderson Cancer Center, University of Texas, Houston, TX).
All media were supplemented with 10% heat-inactivated fetal calf serum. For assays of apoptosis induction, the Jurkat cells were grown at a density of 2 ϫ 10 5 /ml. The ␥-radiation was 25 Gy by using a Cs137 ␥ source. 293T cells were seeded at a density of 2 ϫ 10 4 /cm 2 , transfected ϳ18 h later, and subjected to apoptogenic stimuli ϳ30 h thereafter. Apoptosis was determined as described and validated previously (Sandal et al., 2001 (Sandal et al., , 2002 . The background was generally no more than 5% apoptotic cells, and was subtracted from all individual calculations. Chromatin condensation was judged by microscopy of cells fixed in phosphate-buffered saline containing 2% formaldehyde and 10 g/ml bisbenzimide (Hoechst 33342; Calbiochem, San Diego, CA).
Jurkat T-cells were transfected, using DMRIE-C, with pcDNA3.1 vector carrying Irod cDNA, antisense Irod cDNA (as-Irod), or the empty pcDNA3.1 vector. Stable transfectants were selected with G418 (400 g/ml) for 4 wk. LNCap cells and 293T cells were transfected, using DMRIE-C and CaPO 4 precipitation, respectively, with the pcDNA3.1 constructs described above, doped (1:8) with a GFP reporter gene in pCMX-SAH/Y145F (Ogawa et al., 1995) .
The 293T cells were also transfected with pBabeMN retrovirus constructs containing the 419-base pair cDNA fragment originally isolated from an OA-resistant cell line (Sandal et al., 2001) , with the HA-Irod-GFP and Irod-HA-GFP in pJim-GFP vector (see above), with truncated versions of HA-Irod, coexpressed with GFP, using the IRES bicistronic retroviral vector described previously (Sandal et al., 2002) , and with Bcl-2 (in pBillNeo expression vector, a gift from T.J. McDonnell). To probe the role of CaMKII 293T cells were transfected with the autocamtide-2-related inhibitory peptide (AIP; KKALRRQEAVDAL) (Ishida et al., 1995) , the autocamtide-3 derived inhibitory peptide (AC3-I; KKAL-HRQEAVDAL) (Braun and Schulman, 1995b) Fladmark et al., 2002. Northern Blot and Reverse TranscriptionPolymerase Chain Reaction (RT-PCR) Analysis RNA was extracted from cells by using the TRIzol Reagent (Invitrogen, Paisley, United Kingdom). For Northern blots, the RNA (20 g/lane) was separated on a 1.2% formaldehyde/agarose gel. Irod-specific probes were produced by PCR on pcDNA3.1-Irod vector, resulting in probes specific for either full-length, 5Ј-end or 3Ј-end of the cDNA. Multiple tissue expression array (MTE) and multiple tissue Northern array (MTN; BD Biosciences Clontech) was hybridized with different Irod-specific probes according to the manufacturer's protocol.
To identify the RNA originating from the transfected DNA in Jurkat cells, cDNA was synthesized from total RNA samples using random hexamer primers and AMV-reverse transcriptase. The primary cDNA products were amplified by PCR. For detection of Irod expression, we used a T7 forward primer and an Irod-specific reverse primer (SP4): 5Ј-CATGCTCCATAGACCAC-3Ј. For detection of Irod-antisense expression a BHG reverse primer and an Irod-specific forward primer (SP5) 5Ј-GTTGACACGCCCTCCAT-3Ј. Both reactions were predicted to produce fragments of ϳ1400 base pairs. T7 forward and BHG reverse primers, predicted to produce a 240-base pair fragment, were used to detect the expression of control vector.
Western Blot Analysis
Cell extraction, electrophoresis, blotting, and detection of immunoreactive proteins was as described previously (Sandal et al., 2002) . The membranes were probed with 0.2% monoclonal mouse anti MDM2 (SMP14; Santa Cruz Biotechnology, Santa Cruz, CA), 0.2% monoclonal mouse anti p53 (Bp53-12; Santa Cruz Biotechnology), 1 g/ml of polyclonal rabbit anti-caspase3/CPP32 antibody (AHZ0052; Biosource International, Nivelles, Belgium), 0.4% monoclonal mouse anti-Bcl-2 (ZS18-0193), 0.2% polyclonal rabbit anti-HA (Zymed Laboratories, South San Francisco, CA), 1 g/ml polyclonal rabbit anti-poly(ADP-ribose) polymerase (PARP) (06-557; Upstate Biotechnology, Lace Placid, NY), or 0.1% polyclonal rabbit anti-Bax (N-20; Santa Cruz Biotechnology). Blots were reprobed with 0.01% monoclonal mouse anti ␤-actin (AC-15-ab6276, Abcam Limited, Cambridge, UK).
Immunofluorescence
293T cells growing on coverslips were transfected with Irod-GFP fusion constructs carrying a C-or N-terminal HA epitope (see above) and fixed 30 h thereafter. They were processed for immunofluorescence as described by Srinivasan et al., (1994) , except that the cells were permeabilized with 0.1% Triton X-100, and further incubated overnight at 4°C with 1 mg/ml bovine serum albumin and 0.5% NP-40. Immunostaining was performed using mAb to the HA tag (clone12CA5; Roche Diagnostics, Indianapolis, IN), mAb to the endoplasmic reticulum marker calnexin (a gift from Dr. Ari Helenius, Swiss Federal Institute of Technology, Zurich, Switzerland), or polyclonal antibody to the Golgi marker mannosidase II (a gift from Dr. Kelley Moremen, University of Georgia, Athens, GA). The secondary antibodies (Coulter-Immunotec, Marseille, France) were tetramethylrhodamine B isothiocyanate labeled and used at 20 g/ml. Mitochondria were visualized by staining with MitoTracker dye on live cells, according to manufacturer's protocol (Molecular Probes, Leiden, The Netherlands). Fluorescence was analyzed using a DM IRBE microscope (Leica, Heidelberg, Germany), equipped with fluorescein isothiocyanate and tetramethylrhodamine B isothiocyanate filter optics (Leica). Photomicrographs and image processing was performed using either Openlab software packages (Improvision, Coventry, United Kingdom) or Leica laser scanning confocal NT by using Leica NT software.
Bioinformatics and Statistical Analysis
The identification of putative GTP-binding domain and putative membrane binding domains of Irod was by SMART analysis (http://smart.embl-heidelberg.de/) and of putative coiled-coil regions by COILS (Lupas et al., 1991 (Lupas et al., , 1996a  http://www.ch.embnet.org/software/COILS_form.html. Multiple sequence alignment of human (AK002158) rat (AY055776) and mouse (MacMurray et al., 2002) Irod was performed using the Clustal W multiple sequence alignment package. For determination of statistical significance the Wilcoxon paired signed rank test was used.
RESULTS
Irod Protects Jurkat T-Cells Specifically against Okadaic Acid-and ␥-Radiation-induced Apoptosis
The previously described short cDNA fragment (Oar2) of the gene AK002158 (Irod/Ian5), which in fibroblasts protected against OA-induced death, could act by a number of mechanisms (Sandal et al., 2001) . We reasoned that if Oar2 cDNA coded for a dominantly negative peptide counteracting the proapoptotic action of full-length Irod/Ian5, its action should be mimicked by transfection with antisense-Irod cDNA. If it encoded a proapoptotic peptide, its action should be mimicked by overexpression of full-length Irod. To test this experimentally we cloned AK002158 (Irod) from a human spleen cDNA library, by using Oar-2 cDNA as probe, and produced sense and antisense constructs for cell transfection. Stable expression of the transfected genes in Jurkat T-lymphoma cells was confirmed by RT-PCR ( Figure  1A ). The Irod cells resisted OA-induced apoptosis better than wild-type cells and cells expressing empty vector (Figure 1 , B, E, and H). On the other hand, cells transfected with antisense-Irod cDNA had increased sensitivity to OA-induced death compared with wild-type cells or cells transfected with empty vector (p Ͻ 0.004 as judged by the Wilcoxon paired comparison test). This suggested that Irod itself had an antiapoptotic function.
The specificity of the antiapoptotic effect of Irod was explored using different death inducers. We first subjected the cells to ␥-radiation, to which lymphoid cells are particularly sensitive (Rudner et al., 2001) . The cells overexpressing Irod showed similar resistance toward apoptosis induced by ␥-radiation or OA (Table 1 and Anti-Fas, 5 h, 50 ng/ml 27.7 Ϯ 5 41.6 Ϯ 1.9 36.1 Ϯ 5.5 29.5 Ϯ 4.4 35.5 Ϯ 1.6 22 Ϯ 2.6 1.3 a Cells were treated at a density of 0.3 ϫ 10 6 cells/ml with different death inducers, for time periods and concentrations indicated, followed by fixation in 4% formaldehyde containing Hoechst DNA staining. Apoptotic cells were scored as described in experimental section. b Data represent the mean Ϯ SEM of at least three separate experiments. c Difference in sensitivity towards the various apoptosis inducers in Irod and as-Irod expressing cells was expressed as the ratio IROD/As-IROD, and death inducers were ranked according to this value. d Cotreated with cyclohexemide, 1 g/ml, for 5 hours. When present, KN93 (20 M) was added together with the death inducer.
The cells overexpressing Irod were not protected against UV-C treatment (Table 1) . Ionizing radiation induces double strand breaks in DNA, whereas UV-C radiation is believed to induce apoptosis mainly through single-strand DNA damage (Lu et al., 1998; Lakin and Jackson, 1999 ). It was therefore tested whether cells with enforced Irod expression were protected against bleomycin, which is a radiomimetic agent believed to induce apoptosis mainly via the induction of double-strand breaks in DNA (Benitez-Bribiesca and Sanchez-Suarez, 1999; Tounekti et al., 2001) , or camptothecin, which is a topoisomerase inhibitor known to induce double-strand breaks (Wu et al., 2002) . Irod overexpression afforded only a minor, if any, protection against any of these DNA damage-inducing agents (Table 1) .
In the next series of experiments, the ability of Irod to protect against CD95 (Fas/Apo-1)-mediated apoptosis was tested. Ionizing radiation is believed to activate CD95 (Kasibhatla et al., 1998; Fujimori et al., 2000; Kasibhatla et al., 2000) , and apoptosis in Jurkat cells induced by ionizing radiation and CD95-ligation is subject to common regulation downstream of caspase 8 activation (Boesen-de Cock et al., 1999) . The Irod-overexpressing cells were not protected against CD95 ligation ( Table 1 ), suggesting that Irod acted at a step in the ␥-radiation pathway not shared by CD95-mediated apoptosis. The specificity of Irod was illustrated further by its inability to protect against apoptosis induced by serum withdrawal, daunorubicin, doxorubicin, or staurosporin (Table 1) .
OA and ␥-Radiation Induce Apoptosis through a CaMKII-dependent Pathway Inhibited by Irod, Upstream of Caspase 3 Cleavage
We have recently shown that CaMKII is activated by PP inhibitors such as OA and that CaMKII activity is required for rapid and efficient PP inhibitor-induced death (Fladmark et al., 2002) . If apoptosis induced by ␥-radiation and OA shared a common pathway inhibited by Irod, one might expect the CaMKII inhibitor KN93 to protect against ␥-radiation as well as against OA. In fact, KN93 protected to similar extent against OA-and ␥-radiation-induced apoptosis (Figure 1 , B and C, and Table 1 ). The CaMKII inhibitor and Irod were similar also in not protecting against bleomycin, camptothecin, daunorubicin, TNF-␣, staurosporin, and anti-Fas (Table 1 ). The addition of KN93 did not additionally protect cells overexpressing Irod against either OA ( Figure  1 , B, F, and I) or ␥-radiation ( Figure 1C ). This suggested that Irod might block a CaMKII-dependent step, possibly common for the death pathway induced by ␥-radiation and OA.
The degradation of the caspase substrate PARP and of procaspase 3 occurred slightly earlier in as-Irod transfectants than wild-type cells. These events were retarded in cells with enforced expression of Irod (Figure 2A ). This indicated that Irod acted upstream of caspase 3 cleavage in the death pathway.
To know whether Irod affected the expression level of known apoptosis-modulating proteins, the level of p53, the proapoptotic Bax, and the antiapoptotic Bcl-2 protein was compared in wild-type cells and Jurkat cells stably transfected with Irod or as-Irod cDNA. No difference was noted in basal expression (Figure 2 ). The Jurkat cell p53 level was stable after irradiation. This suggested either that Jurkat cell p53, which is mutated in the C-terminal domain responsible for transactivation (Cheng and Haas, 1990) , was unable to be up-regulated after MDM2 down-regulation, or that MDM2 down-regulation did not occur. were irradiated with 25 Gy (A and B) and incubated for up to 6 h post-␥-radiation, or treated with 800 nM OA in the absence or presence (*) of 100 M caspase inhibitor zVAD-fmk (C). Extracts were processed for Western blotting. The position and size of caspase 3, Bcl-2, Bax, PARP, HDM2, p53, and ␤-actin is indicated. Note stronger cleavage of caspase 3 (A) and PARP (B) in cells expressing as-Irod, and less cleavage in cells expressing Irod. Also note the rapid down-regulation of HDM2 in response to ␥-radiation (B) and OA treatment (C). Similar results were obtained in at least three separate experiments.
We examined next whether the ubiquitin esterase p90 human MDM2 (HDM2) was down-regulated by irradiation or OA treatment. We also considered the possibility that the antiapoptotic effect of Irod could be explained by increase of the p76 splice variant of HDM2. A high expression of HDM2 is associated with hypersensitivity to ionizing radiation (Dilla et al., 2002) , and its 76-kDa splice variant, preferentially expressed in cells with high sensitivity to ionizing radiation, antagonizes p90 HDM2 (Perry et al., 2000; Evans et al., 2001) . Enforced expression of Irod did not affect the resting level of either p90 or p76 HDM2. Neither did it modulate the rapid down-regulation of p90 and p76 HDM2 in response to either ␥-radiation or OA (Figure 2 , B and C), suggesting that Irod might act downstream of this step.
Irod Is Broadly Expressed and Can Confer OA Resistance to Cells Not Related to the Immune System
The AK002158 gene was first identified through a general sequencing effort of a human prostate cDNA library, suggesting that Irod could be expressed and have functions outside the immune system. We tested therefore whether stable enforced expression of Irod could protect also LNCaP prostate carcinoma cells against apoptosis. Irod protected the LNCaP cells better against OA-induced than daunorubicin-induced apoptosis. In contrast, LNCaP cells with stable overexpression of Bcl-2 were protected against daunorubicin-induced death and not against OA ( Figure 3A ). This indicated that Irod acted also on nonimmune cells, and on a death pathway that was completely different from that counteracted by Bcl-2. It could be argued that stable overexpression of Irod or Bcl-2 had led to the selection of cells with secondary properties responsible for the protection against apoptosis. To minimize this risk, we transfected 293T cells transiently with Irod cDNA, and scored them for apoptosis within 48 h after the start of transfection. Such cells were also protected selectively against OA ( Figure 3B ), suggesting that Irod itself was the antiapoptotic factor. Again, Bcl-2 protected against daunorubin-induced death and failed to protect against OA ( Figure 3B ).
The role of CaMKII activity in OA-induced 293T, cell death was established by using the cell-permeable inhibitor KN93 (for discussions of its specificity, see Fladmark et al., 2002) and expression vectors for specific peptide inhibitors of CaMKII. The specificity of these inhibitors is described by Braun and Schulman (1995a) . We observed as efficient inhibition of OA-induced death in cells transfected with the autocamptide-2-related inhibitor KKALRRQEVDAL (AIP) as in cells treated with KN93 ( Figure 3C ). The related inhibitor KKALHRQEVDAL had similar efficiency (our unpublished data), whereas the negative control peptide (KKALD-GEEAVDAL) was inefficient ( Figure 3C ). Cells transfected with CaMKII inhibitor were not additionally protected by Irod cotransfection ( Figure 3C ). The ability of Irod to protect also nonimmune cells against apoptosis prompted us to study the tissue distribution of Irod mRNA. A 1.8-kb mRNA band was detected in Jurkat T-cells and a number of human tissues, by using a probe specific for exon 3 of Irod ( Figure  4A) . A broad tissue distribution of Irod mRNA was revealed also by dot blot analysis (Figure 4, C and D) . A probe specific for exon 2 revealed a similar size mRNA and similar tissue distribution (Sandal and Døskeland, unpublished data) , suggesting a strict coexpression of exons 2 and 3. We conclude that Irod is expressed in a number of nonimmune tissues, some of which (like skeletal muscle and heart) contain mainly proliferatively quiescent long-lived cells. 
Subcellular Localization of Full-Length and Truncated Irod Suggests the Presence of Separate Anchoring Domains for the Golgi/ER and Centrosomal Compartments
We questioned why Oar-2 cDNA, coding for only a small portion of Irod, could protect against apoptosis as well as full-length Irod cDNA. One explanation could be that Irod was processed in cellulo to a fragment encompassing the Oar-2 coded sequence. To know whether Irod was processed, 293T cells were transfected with cDNA for Irod with an N-terminal HA-tag and a C-terminal GFP marker.
Anti-GFP or anti-HA recognized a single peptide band (70 kDa), as predicted for full-length HA-Irod-GFP ( Figure  5A ). Furthermore, a striking colocalization of GFP and HA was revealed at the subcellular level ( Figure 5B ). The HA-Irod-GFP-expressing cells were protected against OA-induced apoptosis to similar extent as cells expressing wild-type Irod ( Figure 5C ), suggesting that the tagged protein has full biological activity and therefore was likely to have folded correctly in the cell. We conclude that Irod is stable and can protect against apoptosis as a full-length protein. The perinuclear localization of HA-Irod-GFP (Figure 6 , B-E, left), suggested a localization of HA-Irod-GFP within centrosomal/Golgi/ER regions. In fact, we observed colocalization of Irod with the ER marker calnexin (Figure 6C ), as well as with the Golgi marker mannosidase II ( Figure 6D ). We did not find any consistent colocalization with a mitochondria-specific dye ( Figure 6E ). This contrasts with the findings for HA-tagged mIan4, which localized to mitochondria when expressed in 293T cells (Daheron et al., 2001) . The possibility remained that Irod could translocate to the mitochondria during apoptogenic stress, but we did not detect any such redistribution of Irod in cells treated with OA (Sandal and Døskeland, unpublished data) .
Irod has a putative C-terminal transmembrane domain. Irod with this domain deleted (⌬⌻⌴-Irod⌬281-307) was mainly associated with the perinuclear, centrosomal region, and had decreased association to the ER and Golgi ( Figure  7 ). This suggested that Irod contained a centrosomal anchoring sequence proximal to the transmembrane domain. Again, Irod behaved differently from mIan4, which assumed a diffuse cytoplasmic distribution when its C-terminal mitochondrial anchor was deleted (Daheron et al., 2001 ).
GTP-binding and Golgi/ER-anchoring Domains of Irod Are Dispensable for Its Antiapoptotic Effect
The 307-residue-long Irod has, in addition the hydrophobic C-terminal domain, an N-terminal highly conserved GTPase domain ( Figure 8A ). Cells expressing Irod lacking the GTP-ase domain (HA-Irod⌬1-153) or the transmembrane domain (HA-Irod⌬281-307) were protected from death as well as cells expressing wild-type Irod ( Figure 8C ). This indicates that residues 153-280 were responsible for the antiapoptotic action of Irod. This region is predicted to contain mainly ␣-helices, with coiled-coil forming potential from residues 255-280 (Figure 8 ). The short Oar-2 cDNA fragment (Sandal et al., 2001 ) was able to attenuate OA- induced apoptosis when stably transfected into prostate carcinoma cells ( Figure 3A ). It was also efficient when transiently transfected in 293T cells, whether controlled by a cytomegalovirus promoter ( Figure 3B ) or a long terminal repeat retroviral promoter ( Figure 8D ). The Oar-2 cDNA encodes for residues 235-285 of Irod, which include the putative coiled-coil region (Figure 8) , suggesting that this region may be pivotal for the antiapoptotic effect of Irod.
DISCUSSION
Irod/Ian5 belongs to a family of proteins with a conserved GTP-binding site, a protein interaction domain, often including a coiled-coil region, and sometimes a transmembrane domain at the C termini (MacMurray et al., 2002 ; see also Cambot et al., 2002; Stamm et al., 2002) and Figure 8 ). The wide tissue distribution of Irod, and its ability to protect also nonimmune cells against apoptosis, suggest that its function may not be restricted to the immune system. The present study is the first direct demonstration of a distinct effect on a cellular process, i.e., antagonism of apoptotic death, for this type of protein in a nonplant cell. The antiapoptotic activity of Irod contrasts with the proapoptotic role of the plant members of the protein family. Another difference is that the GTP-binding domain was dispensable for the antiapoptotic Irod action, whereas both the coiled-coil and the nucleotide binding domain must be expressed for plant resistance protein to be functional (Moffett et al., 2002) . It seems therefore that Irod has evolved differently from the plant resistance proteins not only with respect to overall function (anti-rather than proapoptotic), but also with respect to the mechanistic role of the domains.
Jurkat T-cells transfected with antisense-Irod cDNA became hypersensitive to ␥-radiation and OA, suggesting that the endogenous level of Irod in Jurkat cells can protect against cell death. The level of Irod mRNA in Jurkat cells was comparable to that in many tissues, implying that the basal expression of Irod may be sufficient to protect cells in the intact organism. An in vivo role of Irod is supported by recent observations in the BB rat. In this animal model of autoimmune diabetes type I with lymphopenia, a frameshift mutation creates a stop codon just C-terminal for the GTP-binding domain of rIrod/Ian5 (Hornum et al., 2002; MacMurray et al., 2002) . The immune cells of the BB rat had strongly decreased expression of mRNA for rIrod/Ian5 (Hornum et al., 2002) , leaving the question open of whether the cells lack rIrod/Ian5 or produce a truncated protein. Our finding that Irod has an antiapoptotic action, depending on its central coiled-coil containing domain, but not its GTPbinding domain, suggest that Irod, if expressed in the BB rat, will be nonfunctional with respect to apoptosis antagonism. It is possible that the subset of T-cells lacking in the BB rat may be particularly sensitive to death inducers sharing the death pathway(s) used by ␥-radiation and phosphatase inhibitors such as OA.
In contrast to Irod (Table 1) , the members of the IAP family of antiapoptotic proteins protect against a broad spectrum of apoptogens, including anti-CD95 (Fas/Apo-1), TNF-␣, staurosporine, and etoposide (reviewed in Deveraux and Reed, 1999) . Likewise, the antiapoptotic members of the Bcl-2 family protect T cells and other cells against a number of death inducers, such as staurosporine and daunorubicin ( Figure 3, A and B) , etoposide, and UV-light (Strasser et al., 1995; Adrian et al., 2001) . It is an apparent paradox that autoimmunity can be associated with disrupted expression of the survival protein Irod (see above), as well as with overexpression of the survival protein Bcl-2 (Strasser et al., 1991; Garchon et al., 1994; Mandik-Nayak et al., 2000) . This may be related to the difference between Irod and Bcl-2 with respect to the apoptotic death types they protect against.
Irod lacking the C-terminal putative transmembrane domain was mainly localized to the centrosomal area, whereas nontruncated Irod was localized also to Golgi and ER structures (Figures 6 and 7) . This suggests that the C-terminal domain was not responsible for the centrosomal localization. The presence of both a centrosomal and a Golgi/ER-anchoring domain is not unprecedented. The coiled-coil scaffold protein CG-NAP/AKAP450/350 contains two separate anchoring domains, one to centrosomes and one to Golgi/ER (Takahashi et al., 1999) . The centrosomal/Golgi localization of a member of the Ian protein family is novel. The mIan4 has a C-terminal mitochondrial membrane anchor and assumes a cytoplasmic distribution when this anchor is deleted (Daheron et al., 2001 ). The hImap1 is localized to the ER, whereas Imap38-1 is nuclear (Krucken et al., 1999) . This suggests that the members of this protein family may have evolved to have functions in distinct subcellular compartments.
The centrosome is receiving increasing attention as an important signal transduction center in the cell (Doxsey, 2001; Meraldi and Nigg, 2001; Lange, 2002) . Although no precise centrosomal role has been established in apoptosis, aberrant centrosome duplication has been associated with cell death (Sato et al., 2000) . The present study serves to further incriminate the centrosome in cell death-relevant signaling. The centrosomal/Golgi location may help explain the specificity of the antiapoptotic action of Irod. The centrosome contains scaffolding proteins, many of which contain coiled-coil domains that link enzymes incriminated in cell cycle regulation, apoptosis, protein phosphorylation, and protein turnover to the centrosome and thereby close to Irod (Pockwinse et al., 1997; Fry et al., 1998; Takahashi et al., 1999; Wigley et al., 1999; Fry et al., 2000; Lorson et al., 2000; Verde et al., 2001; Gergely, 2002) . Of particular interest is that the centrosomal/Golgi scaffolding protein CG-NAP/ AKAP450/350 binds the OA targets PP2A and PP1 (Takahashi et al., 1999) . CaMKII is also associated with centrosomes (Pietromonaco et al., 1995; Matsumoto and Maller, 2002) . In the present study, the CaMKII inhibitor KN93 was shown to protect against apoptosis induced by either ␥-radiation or OA, suggesting that ␥-radiation and OA both have apoptotic pathways involving CaMKII. The CaMKII activity is kept in check by dephosphorylation of an autoactivatory phosphorylation. The dephosphorylation is catalyzed by PP1 and PP2A (Hanson and Schulman, 1992 ) and autophosphorylation and CaMKII activity is therefore rapidly activated in cells treated with OA (Døskeland et al., 1990; Mellgren et al., 1995) . CaMKII can also be activated through proteolytic cleavage . The involvement of CaMKII in death induced by ionizing radiation is a novel finding.
In fibroblasts transduced with Oar-2 cDNA, which codes for the core coiled-coil domain of Irod, we noted modulation of the OA-induced phosphorylation of a small subset of proteins, including hypophosphorylation of the CaMKII substrate vimentin (Inagaki et al., 1997) . The intermediate filament protein vimentin is associated with centrosomes (Maro et al., 1984; Trevor et al., 1995) . It is intriguing that the OA-induced vimentin phosphorylation is mimicked in cells depleted of the B55 subunit of PP2A (Turowski et al., 1999) and that the B55/PP2A complex is targeted by ionizing radiation (Guo et al., 2002) . We do not know yet whether hypophosphorylation of vimentin is a bystander phenomenon or is involved in the antiapoptotic action of Irod. Presently, experiments are underway to identify the other proteins whose phosphorylation was modulated by Irod/Oar-2. Hopefully, this will give further clues to the components of the CaMKII-dependent apoptotic pathways activated by ␥-radiation and OA.
In conclusion, Irod seems to be the first animal member of a phylogenetically ancient family of GTP-binding, coiledcoil proteins with a defined function, i.e., to counteract apoptosis induced by OA and ␥-radiation. Irod represents a rare example of a protein with a GTP-binding domain that apparently is dispensable for a major function. Irod was localized to the centrosome via its core and to Golgi/ER via a C-terminal hydrophobic domain, and acted upstream of caspase 3 activation in the apoptotic cascade. Irod provides a link between the apoptotic events induced by ␥-radiation and protein phosphatase-directed toxins like OA. Death induced by ␥-radiation and OA was counteracted by Irod to a similar extent, and both death pathways depended on CaMKII in a way counteracted by Irod. We propose that the numerous toxins evolved to target PP1 and PP2A may cause apoptosis by mimicking a phylogenetically ancient apoptosis pathway induced by ionizing radiation, and for which the centrosome has a pivotal role.
